Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Sector:
Non Energy Minerals
Industry:
Other Metals Or Minerals
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Clearmind Medicine Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Clearmind Medicine Inc market cap is $3.2M.
What is the 52-week high for Clearmind Medicine Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Clearmind Medicine Inc 52 week high is $2.18 as of September 10, 2025.
What is the 52-week low for Clearmind Medicine Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Clearmind Medicine Inc 52 week low is $0.80 as of September 10, 2025.
What is Clearmind Medicine Inc stock price today?
Clearmind Medicine Inc stock price today is $1.03.
What was Clearmind Medicine Inc stock price yesterday?
Clearmind Medicine Inc stock price yesterday was $1.01.
What is the PE ratio of Clearmind Medicine Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Clearmind Medicine Inc’s P/E ratio is -0.85.
What is the Price-to-Book ratio of Clearmind Medicine Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Clearmind Medicine Inc P/B ratio is 2.2534.
What is the 50-day moving average of Clearmind Medicine Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Clearmind Medicine Inc 50-day moving average is $1.01.
